HEALTH AND DRUG ALERTS
- Take patient risk factors and convenience into account when selecting an intravenous immunoglobulin product. // Drugs & Therapy Perspectives;Jan2011, Vol. 27 Issue 1, p23
Intravenous human normal immunoglobulin (IVIg) products are used to treat a variety of immunodeficiency, inflammatory and infectious disorders. Although the efficacy of commercially available IVIg products does not differ to an appreciable extent, the products have differences in their safety...
- Oxazepam/venlafaxine overdose. // Reactions Weekly;8/11/2007, Issue 1164, p19
This article discusses research being done on an adverse effect of oxazepam/venlafaxine. It references a study by J.H.J.M. Meertens and colleagues in the August 2007 issue of the "Journal of Clinical Psychopharmacology." After intentionally ingesting an overdose of oxazepam and venlafaxine, a...
- Minimizing Adverse Drug Events in Older Patients. Pham, Cung B.; Dickman, Robert L. // American Family Physician;12/15/2007, Vol. 76 Issue 12, p1837
Adverse drug events are common in older patients, particularly in those taking at least five medications, but such events are predictable and often preventable. A rational approach to prescribing in older adults integrates physiologic changes of aging with knowledge of pharmacology. Focusing on...
- Gray hair and the value of colleagues. Klasco, Rich // Drug Topics;11/18/2002, Vol. 146 Issue 22, pHSE6
Relates the experiences of the author as pharmacists in improving the patient outcomes and educating physicians. Contribution of the author in pharmacology research; Changes in managing the adverse drug events in patients; Importance of experience in medical practice.
- A NEW ADDICTION? // Good Medicine (Australian Consolidated Press);Dec2006, p12
The article deals with the results of a research which assessed the health effects of Botox. The wrinkle-smoothing effect of Botox may be addictive, suggest the results of a British survey of Botox users presented at a meeting of the British Association of Aesthetic Plastic Surgeons. It has...
- Zoledronic acid. // Reactions Weekly;1/21/2006, Issue 1085, p27
The article presents a case report involving a patient who developed recurrent infections around the right mandibular ramus during treatment with zoledronic acid. The patient was receiving antineoplastic therapy for hormone-refractory prostate cancer.
- Leuprorelin. // Reactions Weekly;Aug2014, Vol. 1512 Issue 1, p26
The article presents a case study of a 65-year-old man who was admitted to hospital for papuloerythroderma after being treated for prostate cancer by using leuprorelin drug.
- Fortifying the Treatment of Prostate Cancer with Physical Activity. Champ, Colin E.; Francis, Lanie; Klement, Rainer J.; Dickerman, Roger; Smith, Ryan P. // Prostate Cancer (20903111);2/10/2016, p1
Over the past decade, significant data have shown that obese men experience a survival detriment after treatment for prostate cancer. While methods to combat obesity are of utmost importance for the prostate cancer patient, newer data reveal the overall metabolic improvements that accompany...
- Levofloxacin. // Reactions Weekly;8/18/2012, Issue 1415, p31
The article describes the cases of eight women and three men aged 40 to 96 years who developed hypoglycaemia while receiving treatment with levofloxacin.